MacroGenics stock holds at USD 4.12 as cash strength stands out

Published on 09/23/2026 at 16:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MacroGenics stock was quoted at USD 4.12 on September 23, 2026, with a market value of USD 262.445 million. Current ratio reached 6.42.

MGNX, US5562221046, Illustration mit AI erstellt.

MacroGenics, Inc. stock (ISIN US5562221046) was quoted at USD 4.12 on September 23, 2026, while the reported market capitalization stood at USD 262.445 million. The share price data identify MGNX as a Nasdaq biotechnology stock, but the available figures also show an issuer-identifier mismatch in the market data: one current company profile assigns MGNX to ISIN US5560991094 rather than the supplied ISIN.

Liquidity figure stands out

According to Eulerpool on September 23, 2026, MacroGenics had a current ratio of 6.42, compared with 2.96 in the previous year. That is a reported year-over-year increase of 116.57 percent, making balance-sheet liquidity the clearest quantified operating signal in the available data.

The same profile classifies the company in the Health sector and Biotechnology industry and describes its work as antibody-based drug research and development for cancer and autoimmune diseases. The profile lists MGNX as the symbol and reports the alternate ISIN US5560991094, which conflicts with the supplied identifier.

Market value remains measurable

A market snapshot published on September 23, 2026, listed MGNX at USD 4.12 and assigned a market capitalization of USD 262.445 million. The quote was shown with a daily change of negative 0.48 percent, but the available snippet did not provide a matching 52-week range, volume, prior close, or time stamp for the MGNX line.

For investors, the numerical contrast is clear: the reported market value was USD 262.445 million, while the current ratio was 6.42, up from 2.96 one year earlier. Those figures describe liquidity and equity value, not profitability, clinical success, commercial revenue, or a valuation conclusion.

Identifier check limits the picture

The available current company profile links the MGNX ticker to MacroGenics and to US5560991094, whereas this request specifies US5562221046. Because the name and ticker are explicitly paired with a different ISIN in a live source, the supplied company identity cannot be carried into a publishable article without risking attribution to the wrong security.